Skip to main content
. 2014 Jan 8;9(1):e85887. doi: 10.1371/journal.pone.0085887

Figure 5. Effect of niclosamide treatment on tumor-associated Gr1+ CD11b+ MDSCs.

Figure 5

Gr1+ CD11b+ cells were gated and analyzed by FCM for the expression of MDSCs. MDSCs isolated from the tumor tissue of 4T1 tumor-bearing mice were treated with vehicle (A); or treated with niclosamide at 10 mg/kg (B); or treated with niclosamide at 20 mg/kg (C). (D) Statistic results of each group. Treatment of niclosamide significantly reduces the number of MDSCs compared with vehicle group. Values represented means ± SD (n = 6; *p<0.05; **p<0.01).